Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-LUNG01)

NCT04656652 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04656652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-LUNG01)
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 21, 2020
Completion date
February 15, 2027
Enrollment
605 (actual)
Sites
209

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer